AU2020102055A4 - Brain-building gel candy and preparation method thereof - Google Patents
Brain-building gel candy and preparation method thereof Download PDFInfo
- Publication number
- AU2020102055A4 AU2020102055A4 AU2020102055A AU2020102055A AU2020102055A4 AU 2020102055 A4 AU2020102055 A4 AU 2020102055A4 AU 2020102055 A AU2020102055 A AU 2020102055A AU 2020102055 A AU2020102055 A AU 2020102055A AU 2020102055 A4 AU2020102055 A4 AU 2020102055A4
- Authority
- AU
- Australia
- Prior art keywords
- parts
- oil
- fatty acid
- brain
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 39
- 229930195729 fatty acid Natural products 0.000 claims abstract description 39
- 239000000194 fatty acid Substances 0.000 claims abstract description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- -1 fatty acid esters Chemical class 0.000 claims abstract description 34
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229920000159 gelatin Polymers 0.000 claims abstract description 24
- 235000019322 gelatine Nutrition 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 23
- 239000008213 purified water Substances 0.000 claims abstract description 22
- 239000007901 soft capsule Substances 0.000 claims abstract description 21
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 21
- 239000000944 linseed oil Substances 0.000 claims abstract description 20
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 19
- 235000011187 glycerol Nutrition 0.000 claims abstract description 18
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 18
- 239000003921 oil Substances 0.000 claims abstract description 18
- 235000019198 oils Nutrition 0.000 claims abstract description 18
- 235000013336 milk Nutrition 0.000 claims abstract description 17
- 239000008267 milk Substances 0.000 claims abstract description 17
- 210000004080 milk Anatomy 0.000 claims abstract description 17
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 claims abstract description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 16
- 239000001188 FEMA 4487 Substances 0.000 claims abstract description 16
- 210000003022 colostrum Anatomy 0.000 claims abstract description 16
- 235000021277 colostrum Nutrition 0.000 claims abstract description 16
- 229960000673 dextrose monohydrate Drugs 0.000 claims abstract description 16
- 239000000600 sorbitol Substances 0.000 claims abstract description 16
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 15
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 15
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 15
- 235000019498 Walnut oil Nutrition 0.000 claims abstract description 15
- 235000013345 egg yolk Nutrition 0.000 claims abstract description 15
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 15
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 15
- 239000011707 mineral Substances 0.000 claims abstract description 15
- 239000010502 orange oil Substances 0.000 claims abstract description 15
- 150000003839 salts Chemical class 0.000 claims abstract description 15
- 239000008170 walnut oil Substances 0.000 claims abstract description 15
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000004383 Steviol glycoside Substances 0.000 claims abstract description 13
- 235000019411 steviol glycoside Nutrition 0.000 claims abstract description 13
- 229930182488 steviol glycoside Natural products 0.000 claims abstract description 13
- 150000008144 steviol glycosides Chemical class 0.000 claims abstract description 13
- 235000019202 steviosides Nutrition 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000000499 gel Substances 0.000 claims description 57
- 239000002994 raw material Substances 0.000 claims description 27
- 229940105990 diglycerin Drugs 0.000 claims description 13
- 235000019502 Orange oil Nutrition 0.000 claims description 12
- 239000000845 maltitol Substances 0.000 claims description 12
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 12
- 235000010449 maltitol Nutrition 0.000 claims description 12
- 229940035436 maltitol Drugs 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 11
- 239000008273 gelatin Substances 0.000 claims description 11
- 235000011852 gelatine desserts Nutrition 0.000 claims description 11
- 241000195493 Cryptophyta Species 0.000 claims description 10
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 229960001031 glucose Drugs 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 239000000940 FEMA 2235 Substances 0.000 claims 4
- 239000000945 filler Substances 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 abstract description 21
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 abstract description 15
- 235000013736 caramel Nutrition 0.000 abstract description 15
- 239000001828 Gelatine Substances 0.000 abstract description 13
- 210000004556 brain Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 239000000413 hydrolysate Substances 0.000 abstract description 10
- 230000015654 memory Effects 0.000 abstract description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract description 5
- 235000005976 Citrus sinensis Nutrition 0.000 abstract description 3
- 240000002319 Citrus sinensis Species 0.000 abstract description 3
- 210000004958 brain cell Anatomy 0.000 abstract description 3
- 230000036995 brain health Effects 0.000 abstract description 2
- 230000001149 cognitive effect Effects 0.000 abstract description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- 235000015816 nutrient absorption Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 26
- 239000000725 suspension Substances 0.000 description 26
- 238000002474 experimental method Methods 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 238000011161 development Methods 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 8
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 8
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 8
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 8
- 241001474374 Blennius Species 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 235000021323 fish oil Nutrition 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000012549 training Methods 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 241001501885 Isochrysis Species 0.000 description 4
- 244000062730 Melissa officinalis Species 0.000 description 4
- 235000010654 Melissa officinalis Nutrition 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 239000004376 Sucralose Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000012716 cod liver oil Nutrition 0.000 description 4
- 239000003026 cod liver oil Substances 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000000265 homogenisation Methods 0.000 description 4
- 239000000865 liniment Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 4
- 235000019408 sucralose Nutrition 0.000 description 4
- 229940038779 valerian root extract Drugs 0.000 description 4
- 239000001192 valeriana officinalis l. rhizome/root Substances 0.000 description 4
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 235000004426 flaxseed Nutrition 0.000 description 3
- 230000009191 jumping Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000206751 Chrysophyceae Species 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241000233671 Schizochytrium Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 150000002066 eicosanoids Chemical class 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 235000016046 other dairy product Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 230000006886 spatial memory Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/40—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the fats used
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/46—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
- A23G3/54—Composite products, e.g. layered, coated, filled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/14—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing fruits, nuts, e.g. almonds, seeds, plants, plant extracts, essential oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2220/00—Products with special structure
- A23G2220/20—Products with special structure with a composite structure, e.g. laminated products, coated products, microstructures, e.g. with encapsulated ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
The present invention is a brain-building gel candy, comprised of a soft capsule shell
and a soft capsule filling. The soft capsule shell contains (by weight): gelatine, purified
water, glycerin, dextrose monohydrate, Sorbitol, caramel colour, and ultra-fine
titanium dioxide. The filing includes active ingredients such as milk mineral salt,
Docosahexaenoic acid (DHA) Algal oil, mushroom oil, hydrolysate of egg yolk powder,
colostrum basic protein and gamma aminobutyric acid. The filling may also contain
auxiliary materials including flaxseed oil, sweet orange oil, walnut oil, monoglyceride
fatty acid esters, diglycerol fatty acid ester, white granulated sugar, and steviol
glycosides. The soft-gel candy is able to improve brain nutrient supply, enhance body
nutrient absorption, enhance children's cognitive, receptive and creative ability,
improve brain cell activity, enhance memory and comprehension ability, and maintain
brain health and vitality.
Description
Brain-building gel candy and preparation method thereof
The technical field is Gel Candy and more specifically brain-building gel candy and the
method of preparation.
Not only are there countless varieties of candy, it has a wide-appeal and is an
indispensable food for many people. The main consumers of candy tend to be children
and as they are in a stage of growing and learning, the development of a brain-building
candy may have a notable social significance and high market value. Soft capsules
are filled with a liquid or paste which fills out a desired shape. This can be used simply
as a container (not to be digested), swallowed whole or crushed.
DHA is the most abundant omega-3 found in the brain and is also important for
maintaining the structure and function of nerve cells. DHA is an important part of cell
membranes, especially in the brain and retina. In the past two decades, the research
and application of fish oil has become a worldwide focus. An Epidemiological survey
found Eskimo's, whose diet is rich in fish oil, have a lower heart disease mortality.
Clinical trials and laboratory studies have confirmed fish oil can regulate blood lipids
(triglycerides), and has anti-thrombosis and anti-inflammatory effects. One of the main
functions of the omega-3 polyunsaturated fatty acids found in fish oil is their ability to
regulate the role of 20 in the body. The balance of eicosanoid prostacyclin I and
thromboxane A (Leaf A. et al, Cardiovascular effects of n-3 fatty acids. N Engl JMed
1988; 318:549). The results of these studies have rewritten the formula of the ratio of
unsaturated fatty acids to saturated fatty acids in the nutritional structure of modern nutrition (7 dietary factors of coronary heart disease, Foreign Medical Hygiene Volume,
1993; 2:62), and enhanced the omega 3 series in food. In view of the fact that omega
3 polyunsaturated fatty acids contained in plant food-a-lionleic acid is very low in
human metabolism. Fish oil which is rich in the precursors of twenty-carbon derivatives
Eicosapentaenoic Acid (EPA) and DHA have become the most ideal omega 3 series
food source of polyunsaturated fatty acids.
At present, the American Institute of Medicine and the International Fatty Acids and
Lipids recommend the daily intake of DHA per person to be 160-200mg. Research
institutions have concluded that DHA and omega-3 polyunsaturated fatty acids are the
health effects of imported DHA and omega-3 polyunsaturated fatty acids (EPA or DHA)
is said to be a complicated task which requires an abundance of information and
system reviews to support. Based on this, most studies first consider the efficacy of
omega-3 long-chain unsaturated fatty acids as a whole, then focus on DHA. The most
important point is the long-term accumulation from the diet, which has an important
effect on our health. In addition, it is often pointed out that a moderate increase in
intake can have an impact on the health effects causes by nonlinear accumulation.
The greatest benefit tends to be the gradual accumulation of low intake in the diet. As
a crucial substance in individuals daily diet, edible oil is the most efficient way to
gradually accumulate DHA or EPA through low-intake. DHA is able to optimise the
phospholipid composition of fatal brain pyramid cells, hugely influencing fetal brain
development during pregnancy. When the foetus is five months old, artificial
stimulation of the foetus's hearing, vision, and touch causes the neutrons in the
sensory centre of the fetal cerebral cortex to grow more dendrites, this requires the
mother to provide the foetus with more DHA. DHA has an important effect on the
development of the foetus's brains as well as playing an important role in the
maturation of retinal light-sensitive cells. During pregnancy, women should consider
increasing their intake of foods rich in a-linolenic acid. The a-linolenic acid in maternal blood is used to synthesise DHA, which is then transported to the foetus's brain and retina helping to mature their nerve cells.
Experiments conducted by the famous American nutritionist Baez and a four-year
follow-up study showed in infancy, supplementation with high levels of DHA (0.36%,
calculated as fat%, about three times the Austin experiment), at 18 the intelligence
development index measured at the age of four months and the IQ (Intelligence
Quotient) value measured at that age were consistently higher than the group of infants
without DHA supplements by seven points.This product is extracted from
Schizochytrium algae, it is rich in DHA and essential omega-3 fatty acids. During
pregnancy and after the baby is born, DHA continues to play an important role in the
development of the brain, nervous system and vision.
Not only does DHA promote vision development for infants, it too helps maintain acute
vision in children and adults. BIO-ISLANDDHA is able to help adults maintain
cholesterol and triglycerides, increase the ration of high-density lipoprotein (HDL)/ low
density lipoprotein (LDL) and supports cardiovascular health. Overall BIO
ISLANDDHA helps adults keep themselves healthy which can lead to a happier
lifestyle.
Seaweed is a marine phytoplankton with an abundance of pharmacological functions
and a broad development of prospects in the food and medicine field. Seaweed oil
contains a large number of unsaturated fatty acids, namely EPA and DHA, these fatty
acids are essential to the human body. Seaweed oil can have preventative and
therapeutic effects on cardiovascular diseases, with an array of positive physiological
effect, leading it to receive widespread attention. There are over 30,000 variations of
micro-algae, recent studies have shown there are a wealth of organic compounds with
unique structures in micro-algae such as polysaccharides, antibiotics, and toxins.
These metabolites have a variety of biological activities. These biologically active substances are essential for the development of both humans and animals.They help with anti-thrombosis, lowering blood lipids, preventing platelet aggregation and relaxing blood vessels. They can have a preventative effect on cardiovascular and cerebrovascular diseases, arthritis, nephritis and more. Additionally, these biologically active substances can also promote the development of brain cells and improved brain function. Marine micro-algae are original producers of EPA and DHA. With the increasing decline of marine fishery resources, marine micro-algae may become the main resource for obtaining these substances. Isochrysis globosum is a widely distributed marine planktonic unicellular algae belonging to the Chrysophyta,
Chrysophyceae, Isochrysis, and Isochrysis family. Due to its small size, fast
reproduction, rich nutrition, moderate movement speed, and no cell wall containing
cellulose, it is easily digested by shellfish larvae and thus is a reliable bait for marine
economic bivalve larvae. Recently, there have been related reports showing how
Isochrysis, gallbladder is rich in n-3 polyunsaturated fatty acids, especially rich in DHA
and EPA.
Aimed at the shortcomings of prior research into gel candy, the present invention
provides a brain-building gel candy and the method of preparation and product. The
purpose of the present invention has been achieved through the following technical
solutions:
A brain-building gel candy with a soft-capsule shell and soft-gel filling.
The soft capsule shell contains the following raw materials in part:
150-220 parts of gelatin, 40-45 parts of purified water, 45-50 parts of glycerin, 38-42
parts of dextrose monohydrate, 40-45 parts of sorbitol, 6-9 parts of caramel colour,
0.5-1.2 parts of ultra-fine titanium dioxide.
In order to adjust the taste of the capsule ingredients, 7-10 parts go Maltitol is added.
Sugar alcohol is not only a taste regulator, when combined with gelatine it produces a
cross-linking reaction making the rubber more capable of locking in moisture which
tastes better when chewed.
The filling includes active ingredients and auxiliary materials. The active ingredients
include milk mineral salt, DHA algae oil, mushroom oil, hydrolysate of egg yolk powder,
colostrum basic protein and gamma aminobutyric acid. The Auxiliary materials are
flaxseed oils, sweetener orange oil, walnut oil, monoglycerin fatty acid ester, diglycerin
fatty acid ester, white granulated sugar and steviol glycosides.
The filling contains the following raw materials in parts:
190-240 parts of milk mineral salt, 5-10 parts of Gamma aminobutyric acid, 57-64 parts
of DHA algal oil, 45-52 parts of mushroom oil, 0.3-1.0 parts of White granulated sugar,
and hydrolysate of egg yolk powder 12-17 parts, colostrum basic protein 8-14 parts,
steviol glycosides 0.1-0.3 parts, flaxseed oil 340-365 parts, orange oil 35-42 parts,
walnut oil 25-32 parts, monoglyceride fatty acid ester 10-14 parts, 10-13 parts of
diglycerin fatty acid ester.
It is preferred the soft capsule shel contains the following materials in parts:
183.1 parts of gelatin, 42.7 parts of purified water, 45.6 parts of glycerin, 38.7 parts of
dextrose monohydrate, 44.5 parts of sorbitol, 7.4 parts of caramel colour, 0.8 parts of
ultra-fine titanium dioxide; 7 parts of maltitol are also added.
The filling should contain the following raw materials in part:
223.7 parts of milk mineral salt, 5.9 parts of Gamma aminobutyric acid, 59.4 parts of
DHA algal oil, 46.4 parts of mushroom oil, 0.38 parts of White granulated sugar, 14.6
parts of hydrolysate of egg yolk powder, and 9.4 parts of colostrum basic protein, 0.17
parts of steviol glycosides, 357 parts of flaxseed oil, 41.5 parts of orange oil, 28.4 parts of walnut oil, 13.8 parts of monoglycerin fatty acid esters, and 10.3 parts of diglycerin fatty acid esters.
It is preferred the soft capsule shell contains the following raw materials in parts:
153.7 parts of gelatin, 43.5 parts of purified water, 44.2 parts of glycerin, 41.7 parts of
dextrose monohydrate, 41.7 parts of sorbitol, 7.5 parts of caramel colour, 0.97 parts of
ultra-fine titanium dioxide; 10 parts of maltitol were also added.
The filling should accurately contain the following raw materials in parts:
224 parts of milk mineral salt, 7.4 parts of Gamma aminobutyric acid, 60.1 parts of
DHA algal oil, 51.7 parts of mushroom oil, 0.75 parts of White granulated sugar, 15.8
parts of hydrolysate of egg yolk powder, 10.9 parts of colostrum basic protein, 0.24
parts of steviol glycosides, 362 parts of flaxseed oil, 41 parts of orange oil, 31 parts of
walnut oil, 12.4 parts of monoglycerin fatty acid esters, and 10.7 parts of diglycerin
fatty acid esters.
It is preferred the soft capsule shell contains the following raw materials in parts:
217.4 parts of gelatin, 41.8 parts of purified water, 42.9 parts of glycerin, 39.1 parts of
dextrose monohydrate, 42.8 parts of sorbitol, 8.7 parts of caramel colour, 0.65 parts of
ultra-fine titanium dioxide; 8.97 parts of maltitol are also added.
The filling should contain the following raw materials in parts:
231 parts of milk mineral salt, 5.4 parts of Gamma aminobutyric acid, 61 parts of DHA
algal oil, 47.8 parts of mushroom oil, 0.39 parts of White granulated sugar, 14.7 parts
of hydrolysate of egg yolk powder, and 9.8 parts of colostrum basic protein, 0.27 parts
of steviol glycosides, 367 parts of flaxseed oil, 37.4 parts of orange oil, 28.3 parts of
walnut oil, 13.4 parts of monoglycerin fatty acid esters, and 11.3 parts of diglycerin
fatty acid esters.
Further the particle size of the ultra-fine titanium dioxide should be 500-800 mesh.
The method for preparing the above-mentioned brain-building gel candy is as followed:
1. Preparing the gel liquid:
Pure water is added to the caramel colour and the first suspension is obtained after
dispersion and homogenisation.
After glycerin and ultra-fine titanium dioxide are mixed and homogenised a second
suspension is obtained.
After mixing the two suspensions, add purified water to further homogenise and refine.
Following this add dextrose monohydrate, maltitol and gelatine, heating to 60-80°C,
stir, degas, and obtain the capsule liquid.
2. Preparing the active nutrient filling:
Flaxseed oil, olive oil, cod liver oil, monoglyceride fatty acid ester, diglyceride fatty acid
ester are heated to 60-80°C, add the formula amount of white granulated sugar,
sucralose, valerian root extract, and balm freeze-dried powder. Stir and keep warm for
-30min.
Once it has cooled down to 545°C, add seaweed powder, stir for 15min and cool to
535°C. This is then homogenised, refined and degased to obtain the active nutrient
filling.
3. Preparing the gel candy:
The prepared soft capsule gel liquid and active nutrient filling are added to the soft
capsule machine. The active nutrient filling are filled into the soft capsule shell, this is
then encapsulated and dried. The calcium-supplemented gel candy is then prepared.
Additionally when preparing the gel liquid, the first suspension and the second
suspension are mixed, homogenised, refined and dextrose monohydrate, sorbitol and
gelatine added at the heating temperature of 72°C.
By adopting the technical strategy as detailed above and the raw materials for
preparing soft capsules, gelatine is processed by denaturing and degrading collagen
from the bones and skins of pig, cattle, sheep and other animals. It contains more than
eight types of L-amino acids and is a form of pure protein, has low fat and cholesterol,
and is easily absorbed. Secondly, gelatine is also used in the food industry which has
a certain auxiliary effect on certain diseases however, it will not cause obesity nor
cause a decrease in physical strength. Gelatine is also a powerful protective colloid
with a strong emulsifying power. Once it has entered the stomach it can inhibit the
aggregation of milk and other proteins due to gastric acid, facilitating food digestion.
Ultra-fine titanium dioxide is applied to food as a whitening agent and colour agent
which can be dissolved in glycerin. After glycerin and ultra-fine titanium dioxide are
mixed, a solution of ultra-fine titanium dioxide is prepared for further mixing with other
raw materials. More thorough mixing.
Outlining the raw materials used in the preparation of the gel candy in the present
invention:
Flaxseed oil, sweet orange oil, walnut oil, monoglyceride fatty acid esters and
diglycerol fatty acid esters are the main raw materials for the gel candy filling. Flaxseed
is a plant protein with high nutritional value, the sum of crude protein, fat and total
sugar content in flaxseed is as high as 84.07%. Flaxseed protein has a complete
variety of amino acids and the essential amino acid content is as high as 51.16%.
Flaxseed oil also contain 53% a-linolenic acid. A-linolenic is an essential fatty acid for
the human body which can be converted into EPA and DHA which are both effective
active ingredients in fish oil.
DHA algae oil and mushroom oil are added to the raw materials when preparing the
gel candy filling. DHA algae oil is commonly referred to as brain gold as
polyunsaturated fatty acids are crucial for the human body. DHA is a main component
for the maintenance of the nervous system cells, the brain and retina. The content in
the human cerebral cortex is as high as 20%, it accounts for the largest proportion in
the retina sitting at roughly 50%. It is therefore very important for the development of
fetal vision and intelligence. The raw material is extracted from artificially cultivated
marine micro-algae which is not transmitted by the food chain, however it is the purest
and safest form of DHA in the world. Additionally, mushroom oil can promote the
absorption of calcium, iron, magnesium, phosphorus, and zinc - this can help prevent
rickets in children.
Milk mineral salt is a nutritional supplement made from whey after removing protein,
lactose and other components of a basic milk protein, becoming more beneficial for
human body absorption. Gamma-Gamma aminobutyric acid, namely y-gamma
aminobutyric acid, promotes the production of hormones in children, the bone 4102,
has the potential function to activate athleticism, helps to develop the nervous system,
is a neurotrophic factor, improves sleep quality, and increases deep sleep time. It can
also effectively improve cerebral blood circulation, increase oxygen supply and
promote brand metabolism.
Hydrolysate of egg yolk powder can increase the number of osteoblasts and promote
the growth of bones and teeth, strengthens and helps to elongate the bone, promotes
calcium deposition, and balances bone composition. Colostrum basic protein is not
only high in protein content, but also contains many rare active proteins that are not
commonly found in other dairy products. Colostrum protein also has a smaller
molecular weight at 30KD. This directly acts on bone cells and promotes bone
metabolism.
To summarise, the present invention has the following beneficial effects:
- The candy improves brain nutrient supply
- Enhances body nutrients absorption
- Enhances children's cognitive, receptive, and creative ability
- Improves brain cell activity
- Enhances memory and comprehensive ability
- Maintains brain health and vitality
The realisations of the present invention are intended to be illustrate and not to limit
the scope of the invention. However, any slight difference in nutrient composition,
which may be caused when using a different milk source, as it may cause an
inconsistency between the embodiments of the present invention and the
specifications. Therefore the invention at hand aims to protect the purpose of adding
nutrients, rather than to make the ratio particularly strict.
EMBODIMENT 1
When preparing brain-building gel candy shell the dosage of each raw material should
be as followed: 153.7 parts of gelatin, 43.5 parts of purified water, 44.2 parts of glycerin,
41.7 parts of dextrose monohydrate, 41.7 parts of sorbitol, 7.5 parts of caramel colour,
0.97 parts of ultra-fine titanium dioxide, 8.97 parts of maltitol.
The filling should contain the folioing raw materials by weight:
224 parts of milk mineral salt, 7.4 parts of Gamma aminobutyric acid, 60.1 parts of
DHA algal oil, 51.7 parts of mushroom oil, 0.75 parts of White granulated sugar, 15.8 parts of hydrolysate of egg yolk powder, 10.9 parts of colostrum basic protein, 0.24 parts of steviol glycosides, 362 parts of flaxseed oil, 41 parts of orange oil, 31 parts of walnut oil, 12.4 parts of monoglycerin fatty acid esters, and 10.7 parts of diglycerin fatty acid esters.
The specific preparation method for this product is as followed:
4. Preparing the gel liquid:
Pure water is added to the caramel colour and the first suspension is obtained after
dispersion and homogenisation.
After glycerin and ultra-fine titanium dioxide are mixed and homogenised a second
suspension is obtained.
After mixing the two suspensions, add purified water to further homogenise and refine.
Following this add dextrose monohydrate, maltitol and gelatine, heating to 60-80°C,
stir, degas, and obtain the capsule liquid.
1. Preparing the active nutrient filling:
Flaxseed oil, olive oil, cod liver oil, monoglyceride fatty acid ester, diglyceride fatty acid
ester are heated to 60-80°C, add the formula amount of white granulated sugar,
sucralose, valerian root extract, and balm freeze-dried powder. Stir and keep warm for
-30min.
Once it has cooled down to 545°C, add seaweed powder, stir for 15min and cool to
535°C. This is then homogenised, refined and degased to obtain the active nutrient
filling.
2. Preparing the gel candy:
Add the prepared gel liquid and active nutrient filling into the soft capsule machine, fill
the active nutrient filling into the gel liquid and enclose the gel liquid, finally dry to
prepare the brain-building gel candy.
When preparing the gel liquid, the mass ratio of the purified water in the caramel colour
and the purified water after mixing the first suspension and the second suspension is
1:9.
Furthermore, when preparing the gel liquid in the first step, after the first suspension
and second suspension are mixed, homogenised and refined, and dextrose
monohydrate, sorbitol and gelatine are added, the heating temperature is 72°C.
EMBODIMENT 2
When preparing the brain-building gel candy shell, the dosage of each raw material is:
217.4 parts of gelatin, 41.8 parts of purified water, 42.9 parts of glycerin, 39.1 parts of
dextrose monohydrate, 42.8 parts of sorbitol, 8.7 parts of caramel colour, 0.65 parts of
ultra-fine titanium dioxide, 10 parts of maltitol.
The filling should accurately contain the following raw materials by weight:
31 parts of milk mineral salt, 5.4 parts of Gamma aminobutyric acid, 61 parts of DHA
algal oil, 47.8 parts of mushroom oil, 0.39 parts of White granulated sugar, 14.7 parts
of hydrolysate of egg yolk powder, and 9.8 parts of colostrum basic protein, 0.27 parts
of steviol glycosides, 367 parts of flaxseed oil, 37.4 parts of orange oil, 28.3 parts of
walnut oil, 13.4 parts of monoglycerin fatty acid esters, and 11.3 parts of diglycerin
fatty acid esters.
The specific preparation method for this product is as followed:
1. Preparing the gel liquid:
Pure water is added to the caramel colour and the first suspension is obtained after
dispersion and homogenisation.
After glycerin and ultra-fine titanium dioxide are mixed and homogenised a second
suspension is obtained.
After mixing the two suspensions, add purified water to further homogenise and refine.
Following this add dextrose monohydrate, maltitol and gelatine, heating to 60-80°C,
stir, degas, and obtain the capsule liquid.
2. Preparing the active nutrient filling:
Flaxseed oil, olive oil, cod liver oil, monoglyceride fatty acid ester, diglyceride fatty acid
ester are heated to 60-80°C, add the formula amount of white granulated sugar,
sucralose, valerian root extract, and balm freeze-dried powder. Stir and keep warm for
-30min.
Once it has cooled down to 545°C, add seaweed powder, stir for 15min and cool to
535°C. This is then homogenised, refined and degased to obtain the active nutrient
filling.
3. Preparing the gel candy:
Add the prepared gel liquid and active nutrient filling into the soft capsule machine, fill
the active nutrient filling into the gel liquid and enclose the gel liquid, finally dry to
prepare the brain-building gel candy.
When preparing the gel liquid, the mass ratio of the purified water in the caramel colour
and the purified water after mixing the first suspension and the second suspension is
1:9.
Furthermore, when preparing the gel liquid in the first step, after the first suspension
and second suspension are mixed, homogenised and refined, and dextrose
monohydrate, sorbitol and gelatine are added, the heating temperature is 72°C.
EMBODIMENT 3
When preparing the brain-building gel candy shell, the dosage of each raw material is:
183.1 parts of gelatin, 42.7 parts of purified water, 45.6 parts of glycerin, 38.7 parts of
dextrose monohydrate, 44.5 parts of sorbitol, 7.4 parts of caramel colour, 0.8 parts of
ultra-fine titanium dioxide; 7 parts of maltitol; The particle size of the ultra-fine titanium
dioxide is 500-800 mesh.
The filling should accurately contain the following raw materials by weight:
223.7 parts of milk mineral salt, 5.9 parts of Gamma aminobutyric acid, 59.4 parts of
DHA algal oil, 46.4 parts of mushroom oil, 0.38 parts of White granulated sugar, 14.6
parts of hydrolysate of egg yolk powder, 9.4 parts of colostrum basic protein, and stevia
0.17 parts of glycosides, 357 parts of flaxseed oil, 41.5 parts of sweet orange oil, 28.4
parts of walnut oil, 13.8 parts of monoglycerin fatty acid esters, and 10.3 parts of
diglycerin fatty acid esters.
The specific preparation method for this product is as followed:
1. Preparing the gel liquid:
Pure water is added to the caramel colour and the first suspension is obtained after
dispersion and homogenisation.
After glycerin and ultra-fine titanium dioxide are mixed and homogenised a second
suspension is obtained.
After mixing the two suspensions, add purified water to further homogenise and refine.
Following this add dextrose monohydrate, maltitol and gelatine, heating to 60-80°C,
stir, degas, and obtain the capsule liquid.
2. Preparing the active nutrient filling:
Flaxseed oil, olive oil, cod liver oil, monoglyceride fatty acid ester, diglyceride fatty acid
ester are heated to 60-80°C, add the formula amount of white granulated sugar,
sucralose, valerian root extract, and balm freeze-dried powder. Stir and keep warm for
-30min.
Once it has cooled down to 545°C, add seaweed powder, stir for 15min and cool to
535°C. This is then homogenised, refined and degased to obtain the active nutrient
filling.
3. Preparing the gel candy:
Add the prepared gel liquid and active nutrient filling into the soft capsule machine, fill
the active nutrient filling into the gel liquid and enclose the gel liquid, finally dry to
prepare the brain-building gel candy.
When preparing the gel liquid, the mass ratio of the purified water in the caramel colour
and the purified water after mixing the first suspension and the second suspension is
1:9.
Furthermore, when preparing the gel liquid in the first step, after the first suspension
and second suspension are mixed, homogenised and refined, and dextrose
monohydrate, sorbitol and gelatine are added, the heating temperature is 72°C.
Product Integrity:
A comparison was conducted in order to inspect the quality of our gel candy at hand
and other commercial gel candies available on the market. The results are shown in
Table 1 and Table 2. It is made clear the gel candy in examples one to three and the
index of water discount that the brain-building gel candy is superior.
Table 1: Texture Analysis (Hardness Unit: G)
Embodiment 1 Embodiment 2 Embodiment 3 Comparison
Oh sample hardness 8955.36 8548.74 8759.18 2639.28
90°C heat 7528.23 7412.51 7631.51 2045.42
preservation 0.5h
hardness
Hardness at 90°C for 6569.38 6391.48 6471.76 1578.74
1h
Degree of hardness 15.93% 13.57% 12.92% 22.56%
change between 0
and 0.5h
Degree of hardness 26.58% 25.40% 26.17% 40.37%
change between 0
and 1h
Table 2: Discount Analysis (Unit: %)
Centrifuge Embodiment 1 Embodiment 2 Embodiment 3 Comparison time
Oh 0.54 0.61 0.57 0.68
0.5h 0.58 0.57 0.55 0.74
1h 0.67 0.65 0.62 0.86
average 0.60 0.61 0.58 0.76
Comparing the brain function of the gel candy by using animal experiments on
improving memory function:
Animal grouping and sample dosage:
A total of 50 mice were used in this experiment, they were randomly divided into five
groups, each with ten mice and each group half male, half female. Among them three
of the groups were experimental and the other two were control groups. They were given ten grams per day of the product at hand and the control groups were given an equal weight of commercial gel candies each day.
The water maze experiment:
This experiment is where animals are made to swim and find platforms hidden in the
water. It is mainly used to test the learning and memory capability of the experiment al
animals, in regard to spacial positioning and orientation.
For the experiment the animals in each group were given continuous samples for four
weeks, the training was started the day after the last sample dose (samples were
continued during the training period). The water tank was equipped with a platform and
the water depth was 15 cm. The mouses is then recorded (in seconds) from the
moment they are released into the water until they reach the platform. The time is
limited to 120 seconds, if they mouse does not reach the platform in this time, it is
recorded as 120 seconds. The training was carried out four times a day for a total of
eleven days. The first seven days we used invisible platform training, which is where
the platform is submerged underwater then, for the next four days visible platform
training is used. Additionally, markers are set up on the platform so the mouse is able
to determine the location of the platform. The results are shown in Table 3.
Table 3: The Effect of Gel Candy on Mice in the Water Maze Experiment
Days Embodiment Embodiment Embodiment Comparison Comparison 1 2 3 1 2
1 55.3 56.1 55.7 55.9 56.2
2 52.1 53.4 52.4 53.1 54.7
3 48.9 47.5 48.6 50.8 52.4
4 44.5 45.3 44.3 48.5 47.5
41.2 42.4 41.5 47.2 46.1
6 36.6 35.7 36.7 42.5 44.3
7 31.5 31.4 31.8 38.6 39.6
8 30.3 31.2 30.2 35.7 36.5
9 28.7 27.5 28.5 32.6 33.4
25.5 25.6 25.8 29.5 30.8
11 23.2 24.1 23.7 27.4 27.9
12 20.7 19.8 20.4 25.8 25.2
13 17.4 16.5 17.1 23.2 23.5
14 14.8 13.9 14.2 21.4 22.7
It can be seen from the results in Table 3 that examples 1-3 in the water maze experiment shows there is a significant improvement in their spatial and working memory and spatial discrimination abilities.
Jumping Platform Experiment: This experiment uses a rectangular reflection boxwith a volume of 1OcmxlOcmx6Ocm, divided into five black partitions. The lower surface is covered with conductive metal grids, the grid spacing is 0.5cm. There is a platform with a height of 4.5cm is placed at the rear left corner of each room and the voltage intensity is controllable. The animal in each group were given a sample of gel candies for four weeks and training was started the day after the last sample dosage. The animals were placed in the reaction box to adapt to the environment for three minutes, the 36V AC was instantly applied. The animals receive electric shocks and their normal response tends to be jumping back to the platform to avoid noxious stimuli. Most animals may jump back to the conductive metal grid again and jump back to the platform after receiving an electric shock. This experiment is conducted for five minutes and the number of electric shocks or errors the mouse receives are recorded. The animal retakes the test after 24 hours, this is the memory retention test. The amount of times the animal is shocked, the latency of the first jump and the total numbers of errors within three minutes are recorded. The results are shown in Table 4.
Table 4: The Effect of Gel Candy on Mice in the Jumping Platform Experiment
project Embodiment Embodime Embodimen Comparison Comparison
1 nt2 t3 1 2
Learning 236.4 245.7 261.8 168.7 182.4 latency
(second)
Number of 0.57 0.54 0.48 2.76 2.54 learning errors
Memory latency 156.3 143.9 152.4 101.7 110.4 (second)
Number of 0.24 0.31 0.27 1.28 1.34 memory errors
It can be seen that in this experiment, examples 1-3 have notable effects on the learning and memory process of mice, while the effects of examples 1-2 are not so distinct. The above are only preferred embodiments of the present invention however this is not limiting the present invention in other forms. Anyone familiar with this specific profession may use technical content disclosed above to change or modify the equivalent changes. For example, any simple modifications or equivalent changes made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still belongs to the protected scope of this invention.
Claims (1)
- CLAIM1. A brain-building gel candy, characterized in that it comprises a soft capsuleskin and a filler wrapped in the soft capsule;The soft capsule skin contains the following raw materials in parts by weight:150-220 parts of gelatin, 40-45 parts of purified water, 45-50 parts of glycerin, 38-42 partsof dextrose monohydrate, 40-45 parts of sorbitol, 6-9 parts of caramel color, 0.5-1.2 partsof ultrafine titanium dioxide; preferred, includes 7-10 parts of maltitol;The filler includes active ingredients and auxiliary materials; the active ingredients includemilk mineral salt, algae oil, mushroom oil, hydrolyzate of egg yolk powder, colostrum basicprotein, and Gamma aminobutyric acid; the auxiliary materials include linseed oil,sweetener Orange oil, walnut oil, monoglycerin fatty acid ester, diglycerin fatty acid ester,white granulated sugar, steviol glycosides;The fill specifically contains the following raw materials by weight: 190-240 parts of milkmineral salt, 5-10 parts of Gamma aminobutyric acid, 57-64 parts of algae oil, 45-52 partsof mushroom oil, 0.3-1.0 parts of white granulated sugar, and 12-17 parts of hydrolyzateof egg yolk powder, 8-14 parts of colostrum basic protein, 0.1-0.3 parts of steviolglycosides, 340-365 parts of linseed oil, 35-42 parts of orange oil, 25-32 parts of walnut oil,-14 parts of monoglyceride fatty acid ester, 10-13 parts of diglycerin fatty acid ester.2. The brain-building gel candy according to claim 1, wherein the soft capsuleskin contains the following raw materials in parts by weight: 183.1 parts ofgelatin, 42.7 parts of purified water, 45.6 parts of glycerin, one water 38.7 parts of glucose, 44.5 parts of sorbitol, 7.4 parts of caramel color, 0.8 parts of ultrafine titanium dioxide;The fill comprises the following raw materials by weight: 223.7 parts of milk mineral salt,5.9 parts of Gamma aminobutyric acid, 59.4 parts of algae oil, 46.4 parts of mushroom oil,0.38 parts of white granulated sugar, 14.6 parts of hydrolyzate of egg yolk powder, and9.4 parts of colostrum basic protein , 0.17 parts of steviol glycosides, 357 parts of linseedoil, 41.5 parts of orange oil, 28.4 parts of walnut oil, 13.8 parts of monoglycerin fatty acidesters, and 10.3 parts of diglycerin fatty acid esters.3. The brain-building gel candy according to claim 1, wherein the soft capsuleskin contains the following raw materials in parts by weight:153.7 parts of gelatin, 43.5 parts of purified water, 44.2 parts of glycerin, 41.7 parts ofdextrose monohydrate, 41.7 parts of sorbitol, 7.5 parts of caramel color, 0.97 parts ofultrafine titanium dioxide;The fill specifically contains the following raw materials by weight: 224 parts of milkmineral salt, 7.4 parts of Gamma aminobutyric acid, 60.1 parts of algae oil, 51.7 parts ofmushroom oil, 0.75 parts of white granulated sugar, 15.8 parts of hydrolyzate of egg yolkpowder, 10.9 parts of colostrum basic protein , 0.24 parts of steviol glycosides, 362 partsof linseed oil, 41 parts of orange oil, 31 parts of walnut oil, 12.4 parts of monoglycerin fattyacid esters, and 10.7 parts of diglycerin fatty acid esters.4. The brain-building gel candy according to claim 1, wherein the soft capsuleskin contains the following raw materials in parts by weight:217.4 parts of gelatin, 41.8 parts of purified water, 42.9 parts of glycerin, 39.1 parts ofdextrose monohydrate, 42.8 parts of sorbitol, 8.7 parts of caramel color, 0.65 parts ofultrafine titanium dioxide;The fill specifically contains the following raw materials by weight: 231 parts of milkmineral salt, 5.4 parts of Gamma aminobutyric acid, 61 parts of algae oil, 47.8 parts ofmushroom oil, 0.39 parts of white granulated sugar, 14.7 parts of hydrolyzate of egg yolkpowder, and 9.8 parts of colostrum basic protein , 0.27 parts of steviol glycosides, 367parts of linseed oil, 37.4 parts of orange oil, 28.3 parts of walnut oil, 13.4 parts ofmonoglycerin fatty acid esters, and 11.3 parts of diglycerin fatty acid esters.5. The brain-building gel candy according to claim 1, wherein the particle sizeof the ultrafine titanium dioxide is 500-800 mesh.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2020102055A AU2020102055A4 (en) | 2020-08-31 | 2020-08-31 | Brain-building gel candy and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2020102055A AU2020102055A4 (en) | 2020-08-31 | 2020-08-31 | Brain-building gel candy and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2020102055A4 true AU2020102055A4 (en) | 2020-10-15 |
Family
ID=72750365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020102055A Active AU2020102055A4 (en) | 2020-08-31 | 2020-08-31 | Brain-building gel candy and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2020102055A4 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109938147A (en) * | 2019-03-29 | 2019-06-28 | 江西美好时光生物科技有限公司 | A kind of low sugar DHA gel candy improving memory and strengthen immunity |
CN112841379A (en) * | 2021-02-01 | 2021-05-28 | 武汉海奥圣医疗科技股份有限公司 | Casein polypeptide gel candy and preparation method thereof |
CN112841380A (en) * | 2021-02-20 | 2021-05-28 | 姚礼群 | Gel candy and preparation method thereof |
CN114631587A (en) * | 2022-04-06 | 2022-06-17 | 霸符(杭州)科技有限公司 | High-calcium soft sweet and preparation method thereof |
-
2020
- 2020-08-31 AU AU2020102055A patent/AU2020102055A4/en active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109938147A (en) * | 2019-03-29 | 2019-06-28 | 江西美好时光生物科技有限公司 | A kind of low sugar DHA gel candy improving memory and strengthen immunity |
CN112841379A (en) * | 2021-02-01 | 2021-05-28 | 武汉海奥圣医疗科技股份有限公司 | Casein polypeptide gel candy and preparation method thereof |
CN112841380A (en) * | 2021-02-20 | 2021-05-28 | 姚礼群 | Gel candy and preparation method thereof |
CN114631587A (en) * | 2022-04-06 | 2022-06-17 | 霸符(杭州)科技有限公司 | High-calcium soft sweet and preparation method thereof |
CN114631587B (en) * | 2022-04-06 | 2024-03-22 | 霸符(杭州)科技有限公司 | High-calcium soft sweet and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020102055A4 (en) | Brain-building gel candy and preparation method thereof | |
CN108835262B (en) | Modified milk powder for improving memory and preparation method thereof | |
CN107136511A (en) | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof | |
CN102987163A (en) | Immune-enhancing feed and preparation method thereof | |
CN104543274B (en) | A kind of soft sweets containing DHA | |
CN106666169A (en) | Alga hair beautifying paste and preparation method thereof | |
CN106614901A (en) | Nut biscuit with functions of improving eyesight and strengthening brain and preparing method thereof | |
CN108185427A (en) | Composition for relieving asthenopia containing flake, theanine and phosphatidylserine | |
CN101631542B (en) | Nerve regeneration agent | |
CA2676795A1 (en) | Skin-beautifying agent | |
NZ767537B2 (en) | Brain-building gel candy and preparation method thereof | |
NZ767537A (en) | Brain-building gel candy and preparation method thereof | |
CN106165869A (en) | A kind of health food improving memory function and preparation method thereof | |
CN109845840A (en) | The preparation method of saturated fatty acid and middle long chain fatty acids structured lipid | |
CN101700080A (en) | Edible oil for specially supplementing alpha-linolenic acid nutrient | |
CN103766507A (en) | Edible oil with health-care function | |
CN111903826A (en) | Brain-strengthening growth-type gel candy and preparation method thereof | |
CN1939156A (en) | Nutrient composition and its production | |
CN110623073A (en) | Formula milk powder beneficial to body height and preparation method thereof | |
KR20130011515A (en) | Health care food comprised of spirulina and product method of it | |
CN106473124A (en) | A kind of compositionss promoting infant intelligent development | |
JP2008307018A (en) | Mulberry leave-containing modified feed | |
CN108719849A (en) | A kind of healthcare function gold sauce and preparation method thereof | |
RU2795704C1 (en) | Method for obtaining grain product containing c-phycocyanin | |
AU2020102056A4 (en) | Calcium supplemented gel candy and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) |